a close up of a pen


Emerald Health Therapeutics Inc. completes C$27.1M bought deal offering

Date closed: 4/20/2017

Value: C$27.1 million

On April 20, 2017, Emerald Health Therapeutics Inc. (Emerald) (TSXV: EMH) closed its bought deal public offering for aggregate gross proceeds of C$27,123,423, including the partial exercise of the over-allotment option. Eight Capital acted as underwriter for the offering.

Emerald, headquartered in Victoria, British Columbia, is a cultivator of high-quality medical cannabis.

BLG represented Eight Capital with a team led by Andrew Powers that included Joe DiPonio.